PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. E. Lacouture, G. A. McArthur, P. B. Chapman, A. Ribas, K. T. Flaherty, R. J. Lee, K. B. Nolop, K. B. Kim, M. Duvic, J. A. Sosman, Dermatology Working Group
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2589958855